Søg i kliniske forsøg efter: Kayser-Jones Brief Oral Health Status Examination (BOHSE)
I alt 1 resultater
-
University of Wisconsin, MadisonRekruttering
Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.
Sponsorer og samarbejdspartnere
- Laboratorios Viñas, S.A.
- Army Hospital, Percy
- HeartPoint Global
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- King Baudouin Foundation
- Manmohan Cardiothoracic Vascular and Transplant Center
- Michael J. Wesley, PhD
- IRCCS Don Gnocchi, Milano, Italy
- Korrus Inc.
- Ruba Musharbash Nutrition Consultancy Center
- Edanz Group Japan Ltd
- Fundación Pública Andaluza Progreso y Salud
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Center for Rare Neurological Diseases, Norcross, GA
- Pharmaspecific
- Walgreens Co.
- Gulsah Ilhan
- Frankel, Amylynne, M.D.
- Ana Paula Costella
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Se den fulde liste
Medicinske tilstande
- Ann Arbor Stage IVB Hodgkin lymfom
- Svækkelse, Koordinering
- Pelvis Tumors
- Patienter, der gennemgår koronararterie bypasstransplantat (CABG) operation, der kræver ekstrakorporal cirkulation
- Koagulationsforstyrrelse Neonatal
- Nyreskade
- Gastroenteritis Rotavirus
- Arteriovenøs misdannelse i hjernen
- Ondartet intrakraniel kimcelletumor
- Ansigtsinddragelse
- Kardiovaskulære resultater
- Ukontrolleret type 2-diabetes mellitus
- Lunge neuroendokrin tumor
- Ankyloserede tænder
- Kognitiv funktion, social 1
- Udviklingssprogsforstyrrelse og sprogsvækkelse
- Lokaliseret ikke-operabel primær leverkræft hos voksne
- Lammelse af stemmebånd eller strubehoved
- Overgangsalderen
- Alvorlig atopisk dermatitis
- Se den fulde liste
Narkotikainterventioner
- Ozanimod
- Miglustat
- Methotrexate
- CD25 behandling
- LDEPA
- Thiotepa
- FHND5071
- Transdermal østradiol
- Apremilast
- Exendin 9-39
- Interferon beta-1b (Betaferon, BAY86-5046)
- Dexmedetomidin
- Camrelizumab til injektion (200 mg, iv), D1, Q2W, 14-dages cyklus
- 5-Fluorouracil
- Interleukin-2
- Insulin
- Lidokain/ketamin
- Guanfacin med forlænget frigivelse
- Rituximab plus CHOP
- Tocilizumab 20 MG/ML intravenøs opløsning [ACTEMRA]
- Se den fulde liste
CROs by country
- Contract Research Organizations in Belarus
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Chile
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Greece
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Morocco
- Contract Research Organizations in Norway
- Contract Research Organizations in South Korea
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Zambia
- CRO list by country